pentobarbital will lessen the extent or effect of lefamulin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Stay away from coadministration of lefamulin with robust or moderate CYP3A inducers unless the reward outweighs hazards. Monitor for reduced efficacy.